wondering what consensus is on leerink biopharma? huge growth in the last couple years, ecm ranked number 1. is it effectively an eb for the industry at this point? where does it rank
| +232 | Downfall of Qatalyst | 45 | 8h |
| +170 | UBS IB 26Q2 a Disaster! Advisory Revenue Down 23%, Capital MarketsDown 5% | 23 | 7h |
| +114 | UBS Americas IB: The Kids’ Table of Wall Street | 15 | 1d |
| +82 | Lincoln International Return Offers | 42 | 2d |
| +58 | London IB BB is a challenge | 36 | 2m |
| +54 | so confused about 28 SA timeline | 27 | 6d |
| +38 | momentum of Rx groups | 12 | 4h |
| +37 | Fired during interview | 6 | 1d |
| +33 | VP Lifestyle at Top BB Coverage Groups | 17 | 1h |
| +31 | SharePoint makes IB hours HELL | 14 | 7h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Based on the most helpful WSO content, Leerink has shown significant growth in recent years, particularly in the biopharma and healthcare sectors. It has been noted for its strong performance in ECM (Equity Capital Markets), even being ranked number one in this area. However, whether it is considered an Elite Boutique (EB) is still up for debate.
While Leerink's growth is impressive, and it is a top destination for those focusing on healthcare and life sciences, there is skepticism about whether it can consistently compete for $10+ billion M&A deals, a hallmark of true EBs. Comparisons to firms like Qatalyst in healthcare (HC) have been made, but achieving that level is seen as a tough challenge.
In terms of ranking, Leerink is certainly regarded as a top-end shop for healthcare, making it a strong platform for future opportunities in private equity (PE), growth equity (GE), and venture capital (VC) recruiting, especially in life sciences.
Sources: Is Leerink Turning Into EB?, Is Leerink Turning Into EB?, Is SVB Leerink Becoming an EB?, What's your Top Stock Pick for 2017
would recommend taking a look at these two threads on WSO.
[Early 2026] The Definitive and Data-Driven Healthcare IB Group Rankings (Biopharma + Broader HC)
Leerink Partners Culture?
Culture is very tough. Good luck.
It’s “Leerink”, good luck
Maiores molestiae ipsum dolorem autem facere est tempore. Vero id laudantium voluptas quidem quis maxime est. Voluptatem voluptates temporibus quas numquam. Eligendi maxime ut minus animi voluptatum velit. Aperiam deserunt enim ratione eligendi ad. Ea excepturi magni qui adipisci est.
Aut occaecati voluptatem sed quo possimus. Dolores sint qui natus nihil iure repellat. Exercitationem aut totam id consequatur ut illo. Doloremque et consequatur voluptatem voluptatem repellat rem error.
Natus tenetur error vero rem. Sunt sit hic ut optio. Aut accusantium quis dignissimos. Aut veniam dolorem voluptatem sit qui minus. Distinctio consequatur sit eius cumque sit. Voluptas et a quod unde saepe quae eos in.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...